Detail akcie Sedana Med Rg online

Business Summary: Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Sedana Medical AB (publ) revenues increased 15% to SEK148.5M. Net loss increased from SEK19.2M to SEK49.1M. Revenues reflect Other direct sales segment increase of 26% to SEK47.8M, Germany segment increase of 3% to SEK83.4M. Higher net loss reflects Net financial items decrease from SEK21.3M (income) to SEK21.2M (expense), Selling/General/Admin Expense increase of 76% to SEK62.4M (expense).